ProVate is a ready-to-use, disposable device that is prescribed to patients to be used at home.
The formalized offering reinforces network’s leadership in the field of social media, health influencers, and leveraging genuine voices for brands.
MDLinx, part of the M3 global network dedicated to innovation in healthcare solutions through digital transformation, appoints Katya Petrova as its chief commercial officer, to lead the organization’s next wave of growth.
The Colorectal Cancer Alliance (Alliance), the leading nonprofit organization dedicated to ending colorectal cancer, has announced the appointment of two new senior leaders to its executive team.
AbelsonTaylor Group has promoted Amy Restko to Group Director of Engagement Strategy in recognition of her success in developing winning brand strategies for clients and delivering customer experiences that drive behavioral change.
CrowdPharm, a Spectrum Science company, announces the appointment of Dan Lutz to Managing Director, Global Network Creative Officer and the promotion of Ray Colon to Managing Director, Chief Creative Officer.
When it comes to designing clinical trials for rare and ultra-rare diseases, there are greater challenges companies must overcome in comparison to chronic disease studies.
Omnichannel marketing has emerged as a crucial strategy for brands navigating the dynamic contemporary healthcare landscape. However, it is often misunderstood as a complex and an overwhelming task by marketers since they must bring together a range of platforms, handle large amounts of data, and ensure consistent messaging.
The ACE Awards will be presented on September 24, in conjunction with the HBA’s 25th Annual Conference in Toronto.
The company announced the recent addition of nine leaders that have joined the global agency network EVERSANA INTOUCH to support ongoing growth. The new leaders span the full array of services provided by EVERSANA INTOUCH, from medical communications to strategic planning to creative execution and account planning.